Sign up today and be a part of the fastest growing B2B platform

All Categories

Call: +91 842 908 8885

Antigen Rapid Test And Pcr

Antigen Rapid Test And Pcr

  • Minimum quantity0
  • Port of dispatchNot-available
  • TypeNot-available
  • Processing time
  • Estimate pricing$ 6
  • PackagingNot-available

Products Description

The rapid response antigen Test has been developed in Canada and is approved for utilization in Canada, Peru,Portugal, Brazil, Australia, Kuwait, Indonesia, the Philippines, and many other countries. The Rapid Response COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset. This test is also authorized for use with NASAL specimen making it easier for application at POC. The test is authorized for use at the Point of Care i.e., in a patient care setting. Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. The antigen is generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection

Products Specification

    Not-available

Supplier information

Classic member

Lakay Business

  • Brazil

Business type - Not-available

Hi, I'm AI-TradeChat
Your personal trade consultant to help you with your trade practices.
Hi, there
Please wait for a while, we are connecting you to AI-TradeChat.